You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Improving delivery of paclitaxel to ovarian cancer via expansile nanoparticles

    SBC: IONIC PHARMACEUTICALS, LLC            Topic: 102

    ABSTRACT A primary challenge in ovarian cancer is preventing tumor recurrence in patients following a resection debulking procedure year survival rate andlt Intraperitoneal IP administration of chemotherapy most notably paclitaxel can improve patient outcomes and prevent local tumor recurrence the principal deterrent to long term survival However despite these modest improvement ...

    SBIR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health
  2. Development and Validation of a Collaborative Web-Based Quantitative Imaging and Dosimetry System for Radiopharmaceutical Therapy

    SBC: RADIOPHARMACEUTICAL IMAGING AND DOSIMETRY, LLC            Topic: NCI

    Radiopharmaceutical therapyRPTis an emerging cancer treatment that delivers radiation directly to cancer cellsThe recent FDA approval ofRa Xofigotmfor resistant metastatic prostate cancer and its commercial success provides an example of the therapeutic and commercial potential of this modalityIn additiondrug companies have large libraries of targets and targeting moleculesProgress in chelators an ...

    SBIR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health
  3. Immuno-PCR for Detection of Toxins in Medicinal Cannabis

    SBC: COURTAGEN LIFE SCIENCES, INC.            Topic: NIDA

    Abstract The overall goal of this project is to develop an optimized assay design and development process to permit the rapid implementation of sensitive bead based immuno PCR assays for the detection of the major bacterial and fungal toxins that are produced by common contaminants of medicinal cannabis The assay process will be developed and validated in Phase I focusing on one important small ...

    SBIR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health
  4. A Circulating Biomarker for use in Monitoring Metastatic Breast Cancer

    SBC: A&G PHARMACEUTICAL, INC.            Topic: NCI

    Significance Despite decreases in the overall number of new breast cancer BC cases reported in the US annually there are still about BC deaths annually from metastatic breast cancer MBC Thus the ability to monitor MBC is important to determine disease status and therapy response While the gold standard imaging is expensive time consuming and slow to detect disease response o ...

    SBIR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health
  5. Development of a Novel Specific and Sensitive Mass Spectrometry Based Protein Ligand Binding Assay to Discover Novel Beta Lactam Antibiotics

    SBC: WARP DRIVE BIO, LLC            Topic: NIAID

    ABSTRACT There is a critical need to discover and develop safe and effective antibiotics for the treatment of multidrug resistant bacterial infections Each year approximately million patients in the US get hospital acquired infections HAIs with a mortality rate of Nearly of the bacteria causing HAIs are resistant to at least one commonly used antibiotic Natural products NPs a ...

    SBIR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health
  6. Long-acting ghrelin for the treatment of ARS

    SBC: EXTEND BIOSCIENCES INC            Topic: R

    Project Summary The threat of a radiation attack or accident isunfortunatelyall too real and could potentially affect a large enough population so as to overwhelm the medical systemTo be prepared for such an eventit is necessary to stockpile effective radiation medical countermeasuresMCMthat are safeeasily administered to large numbers of peopleand effective even when treatment is delayedhrs after ...

    SBIR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health
  7. Point of Care Sensor for Host Gene Response to Pathogen Infection

    SBC: GINER INC            Topic: NIAID

    PROJECT SUMMARY ABSTRACT Point of Care Sensor for Host Gene Response to Pathogen Infection Respiratory tract infections rank as one of the leading causes of illness and death in the world The lack of rapid easy to use and accurate point of care POC diagnostics for early detection of pathogen infections is a main reason behind inappropriate use of antibiotics and the emergence of antibiotic res ...

    SBIR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health
  8. Retinal birefringence imaging for pediatric vision screening

    SBC: REBISCAN, Inc.            Topic: NEI

    Project Summary Abstract ! Amblyopia is vision loss caused by neglect of a structurally normal eye due to strabismus asymmetric refraction anisometropia or deprivation It is irreversible if not treated by age but half of all patients in the US are undetected and untreated until after it is too late making it the leading cause of preventable vision loss REBIScan has developed retinal bir ...

    SBIR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health
  9. Surgical Wound Closure Matrices for the Prevention of Superficial Incisional SSI

    SBC: GEL4MED, INC.            Topic: 300

    The goal of this Phase I SBIR proposal is to test the feasibility of an intra tissue antimicrobial surgical wound matrix in the prevention of superficial surgical site skin infections Surgical Site Infections SSI are the second most common type of health care associated infection HAI occurring in to of patients undergoing surgery in the United States and accounting for approximately ...

    SBIR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health
  10. Protein Engineering of a Biologic Drug Candidate

    SBC: ANTIDOTE THERAPEUTICS INC            Topic: NIDA

    Project Summary Abstract Cigarette smoking is responsible for nearly one half million deaths yr in the U S where direct healthcare costs to treat smoking and smoking attributable illness exceed $ billion year Only smokers achieve long term abstinence using standard of care pharmacotherapies leaving the majority still smoking and seeking alternatives The focus of this project is to ...

    SBIR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government